Search by Drug Name or NDC

NDC 60505-3972-06 Cyclobenzaprine Hydrochloride 15 mg/1 Details

Cyclobenzaprine Hydrochloride 15 mg/1

Cyclobenzaprine Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is CYCLOBENZAPRINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous system to allow the muscles to relax.

Related Packages: 60505-3972-06
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cyclobenzaprine

Product Information

NDC	60505-3972
Product ID	60505-3972_d5ad254d-7c8e-f25b-85d3-07dcbf61fac7
Associated GPIs	75100050107015
GCN Sequence Number	062177
GCN Sequence Number Description	cyclobenzaprine HCl CAP ER 24H 15 MG ORAL
HIC3	H6H
HIC3 Description	SKELETAL MUSCLE RELAXANTS
GCN	97959
HICL Sequence Number	001950
HICL Sequence Number Description	CYCLOBENZAPRINE HCL
Brand/Generic	Generic
Proprietary Name	Cyclobenzaprine Hydrochloride
Proprietary Name Suffix	n/a
Non-Proprietary Name	Cyclobenzaprine Hydrochloride
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	15
Active Ingredient Units	mg/1
Substance Name	CYCLOBENZAPRINE HYDROCHLORIDE
Labeler Name	Apotex Corp.
Pharmaceutical Class	Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA206703
Listing Certified Through	2023-12-31

Package

NDC 60505-3972-06 (60505397206)

Pricing Information	N/A
NDC Package Code	60505-3972-6
Billing NDC	60505397206
Package	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (60505-3972-6)
Marketing Start Date	2019-03-01
NDC Exclude Flag	N